ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES
<p>Aim. To prove the advantage of the long-term controlled antihypertensive therapy compared with the real usual standard therapy in patients with mild to moderate arterial hypertension.</p><p>Material and methods. It was multicenter, randomized, prospective parallel-group study in...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/335 |
| _version_ | 1797714154345201664 |
|---|---|
| author | S. A. Shalnova S. Y. Martsevich A. D. Deev N. P. Kutishenko P. G. Oganov A. N. Britov E. G. Volkova K. I. Ivanov A. M. Kalinina L. I. Katelnitskaya G. D. Kobalava E. V. Kokurina A. O. Conradi S. K. Kukushkin Yu. M. Lopatin N. I. Maksimov V. Y. Mareev I. S. Petelin D. V. Nebieridze G. I. Nechayev L. A. Sokolova A. V. Suslikov I. G. Fomina A. V. Shabalin V. A. Shulman V. V. Yakusevich S. S. Jakushin |
| author_facet | S. A. Shalnova S. Y. Martsevich A. D. Deev N. P. Kutishenko P. G. Oganov A. N. Britov E. G. Volkova K. I. Ivanov A. M. Kalinina L. I. Katelnitskaya G. D. Kobalava E. V. Kokurina A. O. Conradi S. K. Kukushkin Yu. M. Lopatin N. I. Maksimov V. Y. Mareev I. S. Petelin D. V. Nebieridze G. I. Nechayev L. A. Sokolova A. V. Suslikov I. G. Fomina A. V. Shabalin V. A. Shulman V. V. Yakusevich S. S. Jakushin |
| author_sort | S. A. Shalnova |
| collection | DOAJ |
| description | <p>Aim. To prove the advantage of the long-term controlled antihypertensive therapy compared with the real usual standard therapy in patients with mild to moderate arterial hypertension.</p><p>Material and methods. It was multicenter, randomized, prospective parallel-group study in patients with mild to moderate hypertension. One part of patients (treatment group) received the strongly regulated stepped antihypertensive therapy based on ACE-inhibitor spirapril, the second one (control group) continued their usual standard therapy prescribed by doctors of polyclinics or other patient care institutions. The study lasted one year.</p><p>Results. 1742 patients were enrolled in the study, 854 patients were included in the treatment group and 888 – in the control group. 220 patients dropped out of the study by different reasons, and 1552 patients finished the study. There were 651 (37,6%) men and 1081 (62,4%) women. It was substantial decrease in blood pressure in both group, but distinctions between systolic and diastolic blood pressure in the treatment and control group during the study were significant.</p><p>The target levels of blood pressure (systolic < 140 mm Hg and diastolic < 90 mm Hg) were registered substantially more frequent in the patients of treatment group than in control group (69,4% и 39,3% after three months and 83,6% и 66,9% after 12 months of the treatment correspondingly).</p><p>Conclusion. Controlled stepped antihypertensive therapy resulted into more significant decrease in systolic and diastolic blood pressure and more frequent achievement of target levels of blood pressure in comparison with control group. It supposes better prognosis of patients.</p> |
| first_indexed | 2024-03-12T07:47:44Z |
| format | Article |
| id | doaj.art-55265d2cc8bf4faaad32c3b1dd31725d |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T07:47:44Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-55265d2cc8bf4faaad32c3b1dd31725d2023-09-02T20:50:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-01114810.1234/1819-6446-2005-1-4-8335ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIESS. A. Shalnova0S. Y. Martsevich1A. D. Deev2N. P. Kutishenko3P. G. Oganov4A. N. Britov5E. G. Volkova6K. I. Ivanov7A. M. Kalinina8L. I. Katelnitskaya9G. D. Kobalava10E. V. Kokurina11A. O. Conradi12S. K. Kukushkin13Yu. M. Lopatin14N. I. Maksimov15V. Y. Mareev16I. S. Petelin17D. V. Nebieridze18G. I. Nechayev19L. A. Sokolova20A. V. Suslikov21I. G. Fomina22A. V. Shabalin23V. A. Shulman24V. V. Yakusevich25S. S. Jakushin26Государственный научно-исследовательский центр профилактической медицины МЗ и СР РФ, МоскваГосударственный научно-исследовательский центр профилактической медицины МЗ и СР РФ, МоскваГосударственный научно-исследовательский центр профилактической медицины МЗ и СР РФ, МоскваГосударственный научно-исследовательский центр профилактической медицины МЗ и СР РФ, МоскваГосударственный научно-исследовательский центр профилактической медицины МЗ и СР РФ, МоскваФГУ ГНИЦ ПМ МЗ и СР РФ, МоскваУральская медицинская академия, ЧелябинскБольница ЯНЦ СО РАН, ЯкутскФГУ ГНИЦ ПМ МЗ и СР РФ, МоскваРостовский гос. университет, Ростов-на-ДонуРоссийский Университет Дружбы народов, МоскваФГУ ГНИЦ ПМ МЗ и СР РФ, МоскваНИИ кардиологии МЗ и СР РФ, Санкт-ПетербургФГУ ГНИЦ ПМ МЗ и СР РФ, МоскваВолгоградский ГМУРеспубликанская больница № 87, ИжевскИнститут кардиологии РКНПК МЗ и СР РФ, МоскваКлиническая больница № 5, Нижний НовгородФГУ ГНИЦ ПМ МЗ и СР РФ, МоскваОмская Государственная медицинская академияСПб ГМА им.И.И. Мечникова, Санкт-ПетербургБольница Пущинского НЦ РАН, ПущиноМосковская мед. академия им. И.М.СеченоваГКБ № 25, НовосибирскКрасноярский медицинский институтКлиническая больница скорой помощи, ЯрославльРязанский ГМУ<p>Aim. To prove the advantage of the long-term controlled antihypertensive therapy compared with the real usual standard therapy in patients with mild to moderate arterial hypertension.</p><p>Material and methods. It was multicenter, randomized, prospective parallel-group study in patients with mild to moderate hypertension. One part of patients (treatment group) received the strongly regulated stepped antihypertensive therapy based on ACE-inhibitor spirapril, the second one (control group) continued their usual standard therapy prescribed by doctors of polyclinics or other patient care institutions. The study lasted one year.</p><p>Results. 1742 patients were enrolled in the study, 854 patients were included in the treatment group and 888 – in the control group. 220 patients dropped out of the study by different reasons, and 1552 patients finished the study. There were 651 (37,6%) men and 1081 (62,4%) women. It was substantial decrease in blood pressure in both group, but distinctions between systolic and diastolic blood pressure in the treatment and control group during the study were significant.</p><p>The target levels of blood pressure (systolic < 140 mm Hg and diastolic < 90 mm Hg) were registered substantially more frequent in the patients of treatment group than in control group (69,4% и 39,3% after three months and 83,6% и 66,9% after 12 months of the treatment correspondingly).</p><p>Conclusion. Controlled stepped antihypertensive therapy resulted into more significant decrease in systolic and diastolic blood pressure and more frequent achievement of target levels of blood pressure in comparison with control group. It supposes better prognosis of patients.</p>http://www.rpcardio.ru/jour/article/view/335артериальная гипертонияцелевое АДингибиторы АПФступенчатая терапия гипертонии |
| spellingShingle | S. A. Shalnova S. Y. Martsevich A. D. Deev N. P. Kutishenko P. G. Oganov A. N. Britov E. G. Volkova K. I. Ivanov A. M. Kalinina L. I. Katelnitskaya G. D. Kobalava E. V. Kokurina A. O. Conradi S. K. Kukushkin Yu. M. Lopatin N. I. Maksimov V. Y. Mareev I. S. Petelin D. V. Nebieridze G. I. Nechayev L. A. Sokolova A. V. Suslikov I. G. Fomina A. V. Shabalin V. A. Shulman V. V. Yakusevich S. S. Jakushin ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES Рациональная фармакотерапия в кардиологии артериальная гипертония целевое АД ингибиторы АПФ ступенчатая терапия гипертонии |
| title | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES |
| title_full | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES |
| title_fullStr | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES |
| title_full_unstemmed | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES |
| title_short | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES |
| title_sort | arterial hypertension in russia prolog study as a proof method of contemporary therapy opportunities |
| topic | артериальная гипертония целевое АД ингибиторы АПФ ступенчатая терапия гипертонии |
| url | http://www.rpcardio.ru/jour/article/view/335 |
| work_keys_str_mv | AT sashalnova arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT symartsevich arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT addeev arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT npkutishenko arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT pgoganov arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT anbritov arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT egvolkova arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT kiivanov arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT amkalinina arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT likatelnitskaya arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT gdkobalava arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT evkokurina arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT aoconradi arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT skkukushkin arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT yumlopatin arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT nimaksimov arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT vymareev arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT ispetelin arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT dvnebieridze arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT ginechayev arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT lasokolova arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT avsuslikov arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT igfomina arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT avshabalin arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT vashulman arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT vvyakusevich arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities AT ssjakushin arterialhypertensioninrussiaprologstudyasaproofmethodofcontemporarytherapyopportunities |